| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,312 |
2,078 |
$129K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,171 |
1,133 |
$98K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,175 |
1,955 |
$93K |
| 73562 |
|
667 |
517 |
$12K |
| 72100 |
|
204 |
200 |
$4K |
| 20610 |
|
214 |
183 |
$4K |
| 73130 |
|
73 |
62 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
34 |
33 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
382 |
368 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
231 |
224 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
232 |
80 |
$787.74 |
| 99354 |
|
23 |
12 |
$783.04 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
183 |
175 |
$355.16 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
17 |
12 |
$235.06 |
| 73030 |
|
13 |
12 |
$198.10 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
62 |
59 |
$102.86 |
| 97535 |
Self-care/home management training, each 15 minutes |
13 |
12 |
$73.57 |
| J3490 |
Unclassified drugs |
39 |
24 |
$7.88 |
| 99072 |
|
942 |
774 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
40 |
24 |
$0.00 |